PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsCancer stem cell study finds genetic 'root' of disease

BioNews

Cancer stem cell study finds genetic 'root' of disease

Published 16 May 2014 posted in News and appears in BioNews 754

Author

Dr Lanay Griessner

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.

Definitive support for the existence of human cancer stem cells has been found, according to researchers at the University of Oxford and the Karolinska Institutet in Sweden...

Definitive support for the existence of human cancer stem
cells has been found, according
to researchers
at the University of
Oxford
and the Karolinska Institutet in Sweden.

Cancer stem cells (CSCs) are a type of cancer cell
that have the ability to give rise to all the cell types within a tumour. CSCs
are thought to form the 'root' of the
cancer and are responsible for driving its growth and evolution. Their existence, however, has
been debated for decades by the scientific community, as clear
evidence of their appearance in human cancers has so far been
lacking.

'We have identified a subset of cancer cells [and]
shown that these rare cells are invariably the cells in which the cancer
originates', said study author Dr Petter
Woll, from the University of Oxford. 'It
suggests that if you want to cure patients, you would need to target and remove
these cells at the root of the cancer'.

Scientists investigated 15 patients with myelodysplastic syndromes,
where the bone marrow does not make enough healthy blood cells. Over time, MDS
can develop into a form of leukaemia called acute myeloid leukaemia (AML)
through an accumulation of specific genetic mutations.

The researchers took samples of the patients' bone marrow
at several points during the progression of the disease and identified
cancerous cells. By analysing genetic changes, they were able to track the
origin of mutations leading to cancer cell formation. They found a subset of
MDS cells that showed the distinctive markers of stem cells, which they
identified as CSCs as they were the only cell type that was able to fully
reproduce a tumour, supporting the theory that they function as 'roots'.

Current cancer treatments, like chemotherapy, aim to
reduce the overall size of the tumour. Chemotherapy attacks the cells that form
the bulk of the tumour, but might not reach the smaller population of CSCs,
which could then regenerate the tumour and cause a relapse of the disease.

'It's like having dandelions in your lawn. You can pull
out as many as you want, but if you don't get the roots they'll
come back,' explained Dr Woll.

CSCs have been found in a number of human cancers to date,
but the findings have remained controversial as the lab tests used in their
identification were thought to be unreliable.

'In our studies, we avoided the problem of unreliable lab
tests by tracking the origin and development of cancer-driving mutations in MDS
patients', said study lead Professor
Jacobsen.

The results
are promising but should be interpreted with caution as these results are
limited to the MDS and might not be applicable to other forms of cancer. Dr Woll noted: 'We can't offer patients today new
treatments with this knowledge. What it does is give us a target for the
development of more efficient and cancer stem cell specific therapies to
eliminate the cancer'.

Related Articles

PET BioNews
News
13 March 2020 • 2 minutes read

New genetic test could identify 'high risk' bone marrow cancer patients

by Christina Burke

A new way of identifying high-risk bone marrow cancer may help predict which patients will have more aggressive disease...

PET BioNews
News
7 July 2017 • 2 minutes read

Vitamin C and antibiotic combination offers new approach to cancer

by Rachel Reeves

Cancer stem cells, thought to be the root cause of tumour recurrence, could be eradicated using vitamin C and antibiotics, suggests a new study...

PET BioNews
News
19 October 2016 • 2 minutes read

Cancer risk not linked to stem-cell division rates in organs

by Annabel Slater

Cancer risk is not linked to different rates of adult stem-cell division in organs, a study suggests...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
19 September 2016 • 2 minutes read

Acute myeloid leukaemia made up of 'at least 11 subtypes'

by Amina Yonis

A study on the blood cancer acute myeloid leukaemia has shown which combinations of mutations lead to the most aggressive forms of the disease and revealed a complicated picture at the genetic level...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
27 February 2015 • 2 minutes read

Graphene shows cancer treatment potential

by Sophie McLachlan

Researchers have developed a novel approach to cancer treatment using the carbon-based nanomaterial graphene to target cancer stem cells...

Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false colour).
CC BY 4.0
Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false-coloured cryogenic scanning electron micrograph).
News
20 March 2013 • 2 minutes read

Cancer stem cells drive tumour growth, studies confirm

by Dr Greg Ball

Three research groups, each studying a different type of cancer in mice, have published results that support the theory that tumour growth is driven by 'cancer stem cells'....

Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false colour).
CC BY 4.0
Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false-coloured cryogenic scanning electron micrograph).
News
8 March 2013 • 2 minutes read

Stem cell-like origins of ovarian cancer identified

by Dr Daniel Grimes

The source of stem cell-like cells that can give rise to ovarian cancer in mice has been found, reports a study in the journal Nature...

Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false colour).
CC BY 4.0
Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false-coloured cryogenic scanning electron micrograph).
News
30 January 2013 • 2 minutes read

Cancer drugs may boost breast cancer stem cell growth

by Dr Maria Botcharova

Two breast cancer drugs, Avastin and Sutent, may inadvertently aid cancer growth, a study in mice suggests. The drugs, designed to reduce the blood supply to tumours, were found to encourage cancer stem cell growth, potentially fuelling the spread of the cancer...

Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false colour).
CC BY 4.0
Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false-coloured cryogenic scanning electron micrograph).
News
4 January 2013 • 2 minutes read

Immune cells to target cancer created from stem cells

by Dr Greg Ball

Immune cells that can recognise and kill cancer cells have been grown from induced pluripotent stem cells (iPSCs)...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Chemicals in soap 'may contribute to Western world's fertility problems', say scientists after lab study

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

1 August 2022 • 2 minutes read

First UK medical guidelines issued for trans fertility preservation

1 August 2022 • 2 minutes read

Male age has more impact on IVF birth rate than previously thought

8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Complex structures of the human heart bioengineered

8 August 2022 • 1 minute read

Brain tumour gene also linked to childhood cancers

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856